The proposed sales include up to 13.2 million shares of Jubilant FoodWorks, 12 million shares of Jubilant Ingrevia, and 5.6 million shares of Jubilant Pharmova, sources in the know told CNBC-TV18.
The proposed sales include up to 13.2 million shares of Jubilant FoodWorks, 12 million shares of Jubilant Ingrevia, and 5.6 million shares of Jubilant Pharmova, sources in the know told CNBC-TV18.